Home About us Contact
|
Home About us Contact | ||
|
|
||
Containing Products (containing + products)
Selected AbstractsEfficacy of chemical and botanical over-the-counter pediculicides available in Brazil, and off-label treatments, against head lice ex vivoINTERNATIONAL JOURNAL OF DERMATOLOGY, Issue 3 2010André Asenov MD Background, There is a lack of reliable data on the efficacy of over-the-counter (OTC) pediculicides in Brazil. Methods, We performed ex vivo assays of eight marketed pediculicides: 1% permethrin (Kwell®, Clean Hair®, Keltrina®, Nedax®), 0.02% deltamethrin (Deltacid®, Pediderm®), and two "natural" products (Piolho e Lêndea®, Pilogenio®). We also tested 5% permethrin (Keltrina Plus®), traditional home remedies and an ivermectin-based product used in veterinary medicine. Head lice (49,52 per group) were immersed in the compound for 3 min and washed after 20 min to simulate the typical in vivo treatment protocol. Lice were examined for activity up to 24 h using stringent criteria for survival. Results, Of the permethrin containing products, highest mortality was observed with Kwell® and Clean Hair® (97.9 and 90.2% after 4 h). Keltrina®, Nedax®, Keltrina Plus®, and the two deltamethrin-based products showed only a low efficacy of <60% after 4 h. With exception of pure coconut oil (80% mortality after 4 h), home remedies showed a very low efficacy, and both marketed products killed few lice. The ivermectin-based product caused a mortality of 100% after 4 h. Conclusions, Most Brazilian OTC products did not show a satisfactory efficacy against head lice. Resistance may be present. Ivermectin and coconut oil are promising compounds for topical treatment. Laboratory-based tests should be used to assess resistance patterns and to identify formulations of the active ingredient that increase the efficacy. Standardized testing should be performed before a product is licensed for head lice treatment. [source] In vitro effect of oral antiseptics on human immunodeficiency virus-1 and herpes simplex virus type 1JOURNAL OF CLINICAL PERIODONTOLOGY, Issue 7 2001A. A. M. A. Baqui Abstract Aim: The antiviral effectiveness of widely used commercial mouthrinses has not been well studied. A project was undertaken to evaluate and compare the in vitro antiviral effectiveness of essential oil-containing mouthrinses (LA & TLA) and chlorhexidine mouthrinses (PX & CHX) on 2 different enveloped viruses, human immunodeficiency virus (HIV-1) and Herpes simplex virus (HSV-1) McIntyre strain. Method: HIV-189.6 (1×105/ml) and HSV-1 (1×106/ml) in RPMI-1640 medium were treated with two commercially available forms of LA & TLA (tartar control LA), and 2 formulations of chlorhexidine [(PX), 0.12% chlorhexidine & (CHX), 0.2% chlorhexidine] for 30 sec. The antiviral effect was estimated by inhibition of the syncytia formation or the cytopathic effect (CPE) for HIV-1 on MT-2 cells and by inhibition of the plaque formation for HSV-1 on Vero cell monolayers. Results: Undiluted LA, TLA, PX and CHX completely inhibited both HIV-189.6 and HSV-1 McIntyre strain. PX and CHX inhibited HIV-1 up to 1:4 dilution, whereas, LA and TLA inhibited HSV-1 up to 1:2 dilution. The antiviral effects of LA and TLA were found to be similar and also the antiviral effect of PX and CHX were also found to be comparable. Conclusions: The methods used in this investigation allow easy and reproducible evaluations of antiviral efficacy. The anti-HIV-1 and anti-HSV-1 effects of LA, TLA, PX and CHX as evidenced in our in vitro study suggest that we should investigate potential in vivo effects during the use of essential oil-containing or chlorhexidine containing products when used by patients as mouthrinses. If the clinical studies confirm the in vitro data, pre-procedural use by clinicians may be beneficial in reducing viral contamination of bio-aerosols during the delivery of dental care. Zusammenfassung Ziel: Die antivirale Effektivität von breit genutzten kommerziellen Mundwässern wurde bisher nicht gut untersucht. Ein Projekt wurde deshalb aufgenommen, um den in vitro antiviralen Effekt von ätherischen Öl enthaltenden Mundwässern (LA & TLA) und Chlorhexidin Mundwässern (PX & CHX) auf 2 unterschiedlich entwickelte Viren, das menschliche Immundefizienz Virus (HIV-1) und das Herpes simplex Virus (HSV-1) McIntyre Stamm zu evaluieren und zu vergleichen. Methoden: HIV-189.6 (1×105/ml) und HSV-1 (1×106/ml) in RPMI-1640 Medium wurden mit 2 kommerziellen Formen von LA & TLA (Tartarkontrolle LA) und 2 Arten von Chlorhexidin [(PX), 0.12% Chlorhexidin & (CHX), 0.2% Chlorhexidin] für 30 Sekunden behandelt. Der antivirale Effekt wurde durch Inhibition der Syncytiumbildung oder des cytopathischen Effektes (CPE) für HIV-1 auf MT-2 Zellen und durch Inhibition der Plaquebildung für HSV-1 auf Vero Zellmonolayers bestimmt. Ergebnisse: Unverdünntes LA, TLA, PX und CHX inhibierte sowohl HIV-189.6 und HSV-1 McIntyre Stamm. PX und CHX inhibierte HIV-1 bis zu einer 1:4 Verdünnung, während LA und TLA HSV-1 bis zu einer 1:2 Verdünnung inhibierte. Die antiviralen Effekte von LA und TLA wurden gleichwertig gefunden und auch der antivirale Effekt von PX und CHX waren vergleichbar. Zusammenfassung: Die genutzten Methoden in dieser Untersuchung erlaubten leicht und reproduzierbar die Evaluation von antiviralen Effekten. Die anti-HIV-1 und anti-HSV-1 Effekte von LA, TLA, PX und CHX, die in unserer in vitro Studie evident waren, suggerieren, daß wir das Potential der in vivo Effekte während des Gebrauches von ätherischen Öl enthaltenden oder Chlorhexidin enthaltenden Produkten untersuchen sollten, wenn die Patienten dies als Mundwässer benutzen. Wenn die klinischen Studien die in vitro Ergebnisse bestätigen, kann der vorherige Gebrauch durch die Kliniker die virale Kontamination von Bioaerosolen während der durchgeführten zahnäztlichen Behandlung reduzieren. Résumé But: L'efficacité antivirale des bains de bouches largement commercialises n'a pas été bien étudiée. Notre projet a évalué et comparé l'efficité antivirale in vitro de bains de bouche aux huiles essentielles (LA et TLA) et à la chlorexhidine (PX et CHX) sur 2 virus à envelopes, le virus de l'immunodéfiscience acquise 1 (HIV1) et la souche McIntyre du virus de l'Herpes simplex de type 1 (HSV1). Méthode: HIV1896 (1×105/ml) et HSV1 (1×106 ml) dans un milieu RPMI-1640 furent traits avec 2 formes disponibles sur le marché de LA et TLA, et 2 formules de chloxhexidine (PX, 0.12% chlorexhidine et CHX, 0.2% chlorexhidine) pendant 30 s. L'effet antiviral fut estimé par l'inhibition de la formation de syncitia ou par l'effet cytopathique (CPE) pour HIV1, sur des cellules MT2 et par l'inhibition de la formation de plaque pour HSV1 sur des monocouches cellulaires Vero. Résultats: CHX, LA, TLA et PX non dilués inhibaient complètement à la fois HIV1896 et la souche McIntyre HSV1. PX et CHX inhibaient HIV1 jusqu'à une dilution par 4 alors que LA et TLA inhibaient HSV1 jusqu'à une dilution par 2. Les effets antiviraux de LA et TLA étaient similaires, et les effets antiviraux de PX et CHX étaient aussi comparables. Conclusions: Les methodes utilisées pour cette recherche permettent une évaluation facile et reproductible de l'efficacité antivirale. Les effets anti-HIV1 et anti-HSV1 de LA, TLA, PX et CHX trouvés ici in vitro suggèrent que nous recherchions des effects potentiels in vivo lors de l'utilisation de produits contenant des huiles essentielles ou de la chlorexhidine utilisés comme bains de bouches par les patients. Si les études cliniques confirment les données in vitro, l'utilisation préclinique par les praticiens pourrait leur être bénéfique en réduisant la contamination virale des bioaérosols lors des soins dentaires. [source] Composition and Oxidative Stability of a Structured Lipid from Amaranth Oil in a Milk-Based Infant FormulaJOURNAL OF FOOD SCIENCE, Issue 2 2010Ashanty M. Pina-Rodriguez ABSTRACT:, Amaranth oil can be enzymatically modified to match breast milk fat analog requirements. We have developed a structured lipid (SL) from amaranth oil that, in combination with milk fat, delivers recommended amounts of docosahexaenoic acid (DHA) with palmitic acid specifically esterified at the,sn- 2 position of the triacylglycerol (TAG) backbone. The aim of this study was to study the final fatty acid (FA) contribution and oxidation stability of an infant formula prepared using the structured lipid DCAO (DHA-containing customized amaranth oil). DCAO was included as complementary fat in a "prototype" infant formula, and prepared in parallel with a "control" infant formula under the same processing conditions. The same ingredients but different complementary fat sources were used. A blend of the most commonly used vegetable oils (palm olein, soybean, coconut, and high-oleic sunflower oils) for infant formula was used instead of DCAO in the "control" formula. Additionally, "prototype" and "control" infant formulas were compared to a "commercial" product in terms of FA composition. The oxidative stability index (OSI) of the extracted fats from "prototype,""control," and "commercial" infant formulas were evaluated and compared to the OSI of the substrate fat replacers used. DCAO was the least stable compared to other fat analogs. The use of commercial antioxidants in DCAO containing products should prevent oxidation and therefore increase their stability. [source] Repellency of aerosol and cream products containing fennel oil to mosquitoes under laboratory and field conditionsPEST MANAGEMENT SCIENCE (FORMERLY: PESTICIDE SCIENCE), Issue 11 2004Soon-Il Kim Abstract The repellency of fennel (Foeniculum vulgare Miller)-containing products (5% aerosol and 8% cream) against mosquitoes was compared with those of citronella oil, geranium oil and deet, as well as three commercial repellents, Baby Keeper® cream containing IR3535, MeiMei® cream containing citronella and geranium oils, and Repellan S® aerosol containing 19% N,N -diethyl- m -toluamide (deet) under laboratory and field conditions. In a laboratory study with female Aedes aegypti (L), fennel oil exhibited good repellency in a release-in-cage test and repellency in skin and patch tests of the oil was comparable with those of citronella and geranium oils. In paddy field tests with five human volunteers, 5% and 8% fennel oil-containing aerosol and cream produced 84% and 70% repellency, respectively, at 90 min after exposure, whereas Baby Keeper cream and MeiMei cream gave 71% and 57% repellency at 90 min after exposure, respectively, and Repellan S aerosol gave 89% repellency at 210 min. The species and ratio of mosquitoes collected were the genera Culex (44.1%), Anopheles (42.2%), Aedes (7.8%) and Armigeres (5.9%). Fennel oil-containing products could be useful for protection from humans and domestic animals from vector-borne diseases and nuisance caused by mosquitoes. Copyright © 2004 Society of Chemical Industry [source] | |||||||||||||